Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

A genome-wide DNA methylation signature for SETD1B-related syndrome.

Krzyzewska IM, Maas SM, Henneman P, Lip KVD, Venema A, Baranano K, Chassevent A, Aref-Eshghi E, van Essen AJ, Fukuda T, Ikeda H, Jacquemont M, Kim HG, Labalme A, Lewis SME, Lesca G, Madrigal I, Mahida S, Matsumoto N, Rabionet R, Rajcan-Separovic E, Qiao Y, Sadikovic B, Saitsu H, Sweetser DA, Alders M, Mannens MMAM.

Clin Epigenetics. 2019 Nov 4;11(1):156. doi: 10.1186/s13148-019-0749-3.

2.

ATP8A2-related disorders as recessive cerebellar ataxia.

Guissart C, Harrison AN, Benkirane M, Oncel I, Arslan EA, Chassevent AK, Baraῆano K, Larrieu L, Iascone M, Tenconi R, Claustres M, Eroglu-Ertugrul N, Calvas P, Topaloglu H, Molday RS, Koenig M.

J Neurol. 2020 Jan;267(1):203-213. doi: 10.1007/s00415-019-09579-4. Epub 2019 Oct 14.

PMID:
31612321
3.

De Novo Missense Variants in FBXW11 Cause Diverse Developmental Phenotypes Including Brain, Eye, and Digit Anomalies.

Holt RJ, Young RM, Crespo B, Ceroni F, Curry CJ, Bellacchio E, Bax DA, Ciolfi A, Simon M, Fagerberg CR, van Binsbergen E, De Luca A, Memo L, Dobyns WB, Mohammed AA, Clokie SJH, Zazo Seco C, Jiang YH, Sørensen KP, Andersen H, Sullivan J, Powis Z, Chassevent A, Smith-Hicks C, Petrovski S, Antoniadi T, Shashi V, Gelb BD, Wilson SW, Gerrelli D, Tartaglia M, Chassaing N, Calvas P, Ragge NK.

Am J Hum Genet. 2019 Sep 5;105(3):640-657. doi: 10.1016/j.ajhg.2019.07.005. Epub 2019 Aug 8.

4.

The p16(INK4A)/pRb pathway and telomerase activity define a subgroup of Ph+ adult Acute Lymphoblastic Leukemia associated with inferior outcome.

Chien WW, Catallo R, Chebel A, Baranger L, Thomas X, Béné MC, Gerland LM, Schmidt A, Beldjord K, Klein N, Escoffre-Barbe M, Leguay T, Huguet F, Larosa F, Hayette S, Plesa A, Ifrah N, Dombret H, Salles G, Chassevent A, Ffrench M.

Leuk Res. 2015 Apr;39(4):453-61. doi: 10.1016/j.leukres.2015.01.008. Epub 2015 Jan 25.

PMID:
25675863
5.

In vitro and in vivo interactions between glioma and marrow-isolated adult multilineage inducible (MIAMI) cells.

Roger M, Clavreul A, Sindji L, Chassevent A, Schiller PC, Montero-Menei CN, Menei P.

Brain Res. 2012 Sep 14;1473:193-203. doi: 10.1016/j.brainres.2012.07.030. Epub 2012 Jul 20.

PMID:
22819930
6.

Identification of potential prognostic biomarkers for node-negative breast tumours by proteomic analysis: a multicentric 2004 national PHRC study.

Descotes F, Jézéquel P, Spyratos F, Campion L, Grenot C, Lerebours F, Campone M, Guérin-Charbonnel C, Lanoë D, Adams M, André J, Carlioz A, Martin PM, Chassevent A, Jourdan ML, Guette C, Zanella-Cleon I, Ricolleau G.

Int J Oncol. 2012 Jul;41(1):92-104. doi: 10.3892/ijo.2012.1456. Epub 2012 Apr 30.

PMID:
22552268
7.

A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker.

Besson D, Pavageau AH, Valo I, Bourreau A, Bélanger A, Eymerit-Morin C, Moulière A, Chassevent A, Boisdron-Celle M, Morel A, Solassol J, Campone M, Gamelin E, Barré B, Coqueret O, Guette C.

Mol Cell Proteomics. 2011 Dec;10(12):M111.009712. doi: 10.1074/mcp.M111.009712. Epub 2011 Oct 10.

8.

Isolation of a new cell population in the glioblastoma microenvironment.

Clavreul A, Etcheverry A, Chassevent A, Quillien V, Avril T, Jourdan ML, Michalak S, François P, Carré JL, Mosser J; Grand Ouest Glioma Project Network, Menei P.

J Neurooncol. 2012 Feb;106(3):493-504. doi: 10.1007/s11060-011-0701-7. Epub 2011 Sep 18.

PMID:
21928115
9.

Validation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors: A multicentric 2004 national PHRC study.

Jézéquel P, Campion L, Spyratos F, Loussouarn D, Campone M, Guérin-Charbonnel C, Joalland MP, André J, Descotes F, Grenot C, Roy P, Carlioz A, Martin PM, Chassevent A, Jourdan ML, Ricolleau G.

Int J Cancer. 2012 Jul 15;131(2):426-37. doi: 10.1002/ijc.26397. Epub 2011 Oct 20.

10.

DNA Index in childhood acute lymphoblastic leukaemia: a karyotypic method to validate the flow cytometric measurement.

Rachieru-Sourisseau P, Baranger L, Dastugue N, Robert A, Geneviève F, Kuhlein E, Chassevent A.

Int J Lab Hematol. 2010 Jun;32(3):288-98. doi: 10.1111/j.1751-553X.2009.01189.x. Epub 2009 Sep 28.

PMID:
19793113
11.

Human glioma cell culture: two FCS-free media could be recommended for clinical use in immunotherapy.

Clavreul A, Jean I, Preisser L, Chassevent A, Sapin A, Michalak S, Menei P.

In Vitro Cell Dev Biol Anim. 2009 Oct;45(9):500-11. doi: 10.1007/s11626-009-9215-4. Epub 2009 Jun 16.

PMID:
19533255
12.

MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: a molecular portrait of stage 4S.

Bénard J, Raguénez G, Kauffmann A, Valent A, Ripoche H, Joulin V, Job B, Danglot G, Cantais S, Robert T, Terrier-Lacombe MJ, Chassevent A, Koscielny S, Fischer M, Berthold F, Lipinski M, Tursz T, Dessen P, Lazar V, Valteau-Couanet D.

Mol Oncol. 2008 Oct;2(3):261-71. doi: 10.1016/j.molonc.2008.07.002. Epub 2008 Jul 23.

13.

Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study.

Huguet F, Leguay T, Raffoux E, Thomas X, Beldjord K, Delabesse E, Chevallier P, Buzyn A, Delannoy A, Chalandon Y, Vernant JP, Lafage-Pochitaloff M, Chassevent A, Lhéritier V, Macintyre E, Béné MC, Ifrah N, Dombret H.

J Clin Oncol. 2009 Feb 20;27(6):911-8. doi: 10.1200/JCO.2008.18.6916. Epub 2009 Jan 5. Erratum in: J Clin Oncol. 2009 May 20;27(15):2574. Dosage error in article text.

PMID:
19124805
14.

Pure mucinous carcinomas of the breast: prognostic study including DNA flow cytometry.

Morand C, Verrièle V, Valo I, Remoue P, Paillocher N, Chassevent A.

Cytometry B Clin Cytom. 2009 Jan;76(1):56-62. doi: 10.1002/cyto.b.20436. Epub 2008 Jul 18.

15.

[Kimberly and her blogs].

Vandermersch N, Venisse JL, Chassevent A.

Arch Pediatr. 2008 Jun;15(5):806-7. doi: 10.1016/S0929-693X(08)71919-5. French. No abstract available.

PMID:
18582758
16.

Quantitative analysis of BRCA1, BRCA2 and Hmsh2 mRNA expression in colorectal Lieberkühnien adenocarcinomas and matched normal mucosa: relationship with cellular proliferation.

Le Corre L, Vissac-Sabatier C, Chalabi N, Bignon YJ, Daver A, Chassevent A, Bernard-Gallon DJ.

Anticancer Res. 2005 May-Jun;25(3B):2009-16.

17.

Prognostic value of uPA, PAI-1, and DNA content in adult renal cell carcinoma.

Chautard D, Dalifard I, Chassevent A, Guyetant S, Daver A, Vielle B, Soret JY.

Urology. 2004 Jun;63(6):1055-60.

PMID:
15183949
18.

Flow cytometric S-phase fraction measurement in breast carcinoma: Influence of software and histogram resolution.

Jourdan ML, Ferrero-Poüs M, Spyratos F, Romain S, Martin PM, Chassevent A.

Cytometry. 2002 Jun 1;48(2):66-70.

19.

DNA and cell cycle analysis as prognostic indicators in breast tumors revisited.

Bagwell CB, Clark GM, Spyratos F, Chassevent A, Bendahl PO, Stål O, Killander D, Jourdan ML, Romain S, Hunsberger B, Wright S, Baldetorp B.

Clin Lab Med. 2001 Dec;21(4):875-95, x. Review.

PMID:
11770293
20.

Optimizing flow cytometric DNA ploidy and S-phase fraction as independent prognostic markers for node-negative breast cancer specimens.

Bagwell CB, Clark GM, Spyratos F, Chassevent A, Bendahl PO, Stål O, Killander D, Jourdan ML, Romain S, Hunsberger B, Baldetorp B.

Cytometry. 2001 Jun 15;46(3):121-35.

21.

Experimental assessment of tumor growth and dissemination of a microscopic peritoneal carcinomatosis after CO2 peritoneal insufflation or laparotomy.

Fondrinier E, Boisdron-Celle M, Chassevent A, Lorimier G, Gamelin E.

Surg Endosc. 2001 Aug;15(8):843-8. Epub 2001 May 7.

PMID:
11443420
22.

S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study.

Chassevent A, Jourdan ML, Romain S, Descotes F, Colonna M, Martin PM, Bolla M, Spyratos F.

Clin Cancer Res. 2001 Apr;7(4):909-17.

23.

[Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer: multicentric retrospective study II. DNA-ploidy and S-phase fraction].

Chassevent A, Jourdan ML, Ferrero-Poüs M, Colonna M, Romain S, Spyratos F, Roth H, Bolla M.

Bull Cancer. 1999 Jul-Aug;86(7-8):685-91. French.

24.

Human renal cell carcinoma xenografts in SCID mice: tumorigenicity correlates with a poor clinical prognosis.

Angevin E, Glukhova L, Pavon C, Chassevent A, Terrier-Lacombe MJ, Goguel AF, Bougaran J, Ardouin P, Court BH, Perrin JL, Vallancien G, Triebel F, Escudier B.

Lab Invest. 1999 Jul;79(7):879-88.

PMID:
10418828
25.

Comparative analysis of prognostic indicators for sarcomas of the soft parts and the viscerae.

Rudolph P, Bonichon F, Gloeckner K, Collin F, Chassevent A, Schmidt D, Coindre JM, Parwaresch R, Klöppel G.

Verh Dtsch Ges Pathol. 1998;82:246-52.

PMID:
10095442
26.

[Flow cytometry in cancer of the bladder].

Chassevent A, Allain YM, Chautard D, Larra F, Lépinard V, Soret JY.

Cancer Radiother. 1998 Apr;2 Suppl 1:12s-15s. Review. French.

PMID:
9749070
27.
28.

[Prognostic value of flow cytometry in squamous cell bronchogenic cancer. A retrospective study of 61 cases].

Jeanfaivre T, Chassevent A, Geslin J, Larra F, Tuchais E.

Bull Cancer. 1997 Jun;84(6):597-602. French.

29.

Prognostic relevance of a novel proliferation marker, Ki-S11, for soft-tissue sarcoma. A multivariate study.

Rudolph P, Kellner U, Chassevent A, Collin F, Bonichon F, Parwaresch R, Coindre JM.

Am J Pathol. 1997 Jun;150(6):1997-2007.

30.
31.

1,25-Dihydroxyvitamin D3 induces programmed cell death in a rat glioma cell line.

Baudet C, Chevalier G, Chassevent A, Canova C, Filmon R, Larra F, Brachet P, Wion D.

J Neurosci Res. 1996 Dec 1;46(5):540-50.

PMID:
8951666
32.

Quality control study by the French Cytometry Association on flow cytometric DNA content and S-phase fraction (S%). The Association Française de Cytométrie.

D'hautcourt JL, Spyratos F, Chassevent A.

Cytometry. 1996 Mar 15;26(1):32-9. Erratum in: Cytometry 1996 Jun 15;26(2):183.

33.

[Prognostic evaluation of small cell lung carcinoma by flow cytometry. A retrospective study from bronchial brushing samples].

Jeanfaivre T, Chassevent A, Berruchon J, Savary L, Chrétien MF, Geslin J, Larra F, Tuchais E.

Bull Cancer. 1995;82(5):364-70. French.

PMID:
7626844
34.

[Contribution of flow cytometry in the prognostic evaluation of non-small-cell lung cancers. Review of the literature].

Jeanfaivre T, Chassevent A, Larra F, Tuchais E.

Bull Cancer. 1994 Jul;81(7):605-9. Review. French.

PMID:
7742603
35.

[Analysis of cellular DNA content by flow cytometry in epidermoid carcinoma of the esophagus].

Charneau J, Chassevent A, Delaby J, Ben Bouali AK, Larra F, Boyer J.

Gastroenterol Clin Biol. 1992;16(2):155-61. French.

PMID:
1568543
36.

[Analysis of DNA of renal cell carcinomas by flow cytometry].

Chassevent A.

Arch Anat Cytol Pathol. 1992;40(5-6):307-11. Review. French.

PMID:
1304118
37.

[Evaluation of cell DNA content by flow cytometry: prognostic value in cancer].

Larra F, Chassevent A.

Rev Prat. 1990 Dec 11;40(29):2724-7. French. No abstract available.

PMID:
2281283
38.

Flow cytometric analysis of DNA abnormalities in colorectal carcinomas.

Bocquillon PG, Daver A, Page M, Dalifard I, Chassevent A, Cellier P, Bertrand G, Larra F, George P, Chabrun B, et al.

Bull Cancer. 1989;76(3):291-300.

PMID:
2736315
39.

[Flow cytometry. Results and research potential in solid tumors].

Chassevent A, Bertrand G.

Ann Pathol. 1989;9(4):229-32. Review. French. No abstract available.

PMID:
2675863
40.

Flow cytometric DNA analysis in the diagnosis of lung tumors. A comparison with conventional methods.

Chretien MF, Chassevent A, Malkani K, Rebel A.

Anal Quant Cytol Histol. 1988 Aug;10(4):251-5.

PMID:
3166670
41.

Flow cytometric studies of colorectal tumors using fine needle aspiration.

Daver A, Bocquillon PG, Pagé M, Dalifard I, Chassevent A, Litas P, Cellier P, Bertrand G, Larra F, George P, et al.

Anticancer Res. 1987 May-Jun;7(3 Pt B):531-4.

PMID:
3631913
42.

Flow DNA analysis in human lung cancer: potentiality and limitations due to sampling methods.

Chassevent A, Berruchon J, Bertrand G, Chretien MF, Tuchais C, George P, Larra F, Rebel A, Oury M.

Biol Cell. 1986;58(2):121-6.

PMID:
2950950
43.

Comparative flow DNA analysis of different cell suspensions in breast carcinoma.

Chassevent A, Daver A, Bertrand G, Coic H, Geslin J, Bidabe MC, George P, Larra F.

Cytometry. 1984 May;5(3):263-7.

44.

[Analysis of DNA by flow cytometry in breast cancer].

Chassevent A, Daver A, Bertrand G, Larra F, George P.

Bull Cancer. 1984;71(5):494-5. French. No abstract available.

PMID:
6098324
45.

[beta2-Microglobulin in cancer patients (author's transl)].

Daver A, Chassevent A, Bouali AB, Bertrand AF, Deroche C, Cellier P, Tuchais C, Souaille C, Maillart P, Bertrand G, Minier JF, Larra F, Agerup B.

Pathol Biol (Paris). 1978 Sep;26(6):335-40. French.

PMID:
83577

Supplemental Content

Loading ...
Support Center